Gemer Sita Ir 50/1000/2

GEMER SITA IR 50/1000/2, manufactured by SUN PHARMA LABORATORIES LTD., is a fixed-dose combination medication used in the management of type 2 diabetes mellitus.

• Name:
  • Brand Name: GEMER SITA IR 50/1000/2
• Composition:
  • Each film-coated tablet contains:
    • Sitagliptin Phosphate Monohydrate equivalent to Sitagliptin: 50 mg
    • Metformin Hydrochloride IP: 1000 mg
    • Glimepiride IP: 2 mg
• Uses: GEMER SITA IR is prescribed as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It works by increasing insulin release, decreasing glucose production in the liver, and improving the body's sensitivity to insulin.
• Dosage and Administration: The usual recommended dose is one tablet twice-daily orally, typically taken 15-30 minutes before a meal to minimize gastrointestinal side effects. Dosage should be individualized by a healthcare provider based on the patient's current regimen, effectiveness, and tolerability, not exceeding daily maximums of 100 mg sitagliptin, 2000 mg metformin, and 8 mg glimepiride.
• Side Effects:
  • Common: Vomiting, diarrhea, nausea, abdominal pain, headache, nasopharyngitis, upper respiratory tract infection, and hypoglycemia (low blood sugar).
  • Serious: Lactic acidosis and hypersensitivity reactions.
• Precautions:
  • Pregnancy & Breastfeeding: Avoid during pregnancy, especially in the second and third trimesters, and generally not recommended during breastfeeding.
  • Alcohol: Limit or avoid alcohol due to increased risk of hypoglycemia and lactic acidosis.
  • Renal/Hepatic Impairment: Contraindicated in severe kidney problems (eGFR below 30 mL/min/1.73 m²) and not recommended in hepatic impairment.
  • Elderly & Children: Use with caution in the elderly due to increased hypoglycemia risk; not recommended for pediatric patients.
  • Drug Interactions: Inform your doctor about all medications as several potential drug interactions exist.
  • Driving: May cause dizziness or drowsiness if hypoglycemia occurs; exercise caution.
• Storage: Store at room temperature (20-25°C or below 30°C), protected from moisture and light, and out of reach of children.

Here are frequently asked questions about GEMER SITA IR 50/1000/2:

What is GEMER SITA IR 50/1000/2 used for?

GEMER SITA IR 50/1000/2 is a combination medication used to treat type 2 diabetes mellitus in adults. It helps control high blood sugar levels when diet and exercise alone are not sufficient, or when simpler treatments have not been effective. This medicine helps improve blood sugar control, enhance insulin sensitivity, and reduce the risk of diabetes-associated complications.

How does GEMER SITA IR 50/1000/2 work?

This medication combines three active ingredients: Sitagliptin (50mg), Metformin Hydrochloride (1000mg), and Glimepiride (2mg).

• Sitagliptin (a DPP-4 inhibitor) increases the levels of incretin hormones, which helps the pancreas release more insulin and decreases glucagon secretion, particularly after meals.
• Metformin (a biguanide) reduces glucose production in the liver, delays sugar absorption from the intestines, and improves the body's sensitivity to insulin.
• Glimepiride (a sulfonylurea) stimulates the beta cells in the pancreas to produce and release more insulin. Together, these components work synergistically to achieve comprehensive blood sugar control.

What is the usual dosage for GEMER SITA IR 50/1000/2?

The recommended dosage is individualized by your physician based on your blood glucose levels, HbA1c, and response to treatment. Typically, the starting dose is one tablet taken once or twice daily, usually 15-30 minutes before a meal, to minimize gastrointestinal side effects. It is crucial to adhere strictly to the prescribed dosage and schedule and not to exceed the maximum recommended daily dose of each individual component.

What are the possible side effects of GEMER SITA IR 50/1000/2?

Common side effects may include nausea, vomiting, diarrhea, abdominal pain, metallic taste, headache, dizziness, and hypoglycemia (low blood sugar). Less common but potentially serious side effects can include lactic acidosis (due to metformin accumulation, especially with kidney impairment), pancreatitis, and severe allergic reactions (e.g., rash, itching, swelling). Consult your doctor immediately if you experience persistent or severe side effects.

Is GEMER SITA IR 50/1000/2 safe during pregnancy or breastfeeding?

GEMER SITA IR 50/1000/2 is generally not recommended and should be avoided during pregnancy, especially during the second and third trimesters, as animal studies have shown harmful effects on the developing baby. It is also generally contraindicated or not recommended during breastfeeding, as limited human data suggests the drug may pass into breast milk and could harm the baby. Always consult your doctor for safer alternatives if you are pregnant or breastfeeding.

Can GEMER SITA IR 50/1000/2 be taken with other medications?

Yes, GEMER SITA IR 50/1000/2 can interact with certain medications. It is important to inform your doctor about all prescription drugs, over-the-counter medications, herbal supplements, and vitamins you are currently taking to avoid potential interactions. For example, carbonic anhydrase inhibitors (e.g., topiramate), kidney transport inhibitors (e.g., ranolazine), and beta-blockers (e.g., propranolol) can interact with this medicine. When colesevelam is coadministered with glimepiride, it can reduce the exposure to glimepiride, so GEMER SITA IR should be administered at least 4 hours prior to colesevelam.

What precautions should be taken while using GEMER SITA IR 50/1000/2?

• Kidney and Liver Function: This medicine should be used with caution in patients with kidney or liver problems, and it is contraindicated in severe cases (e.g., eGFR below 30 mL/min/1.73 m² for kidney function). Your doctor will assess and monitor your kidney and liver function regularly.
• Alcohol: Avoid consuming alcohol while taking this medication as it can increase the risk of hypoglycemia (low blood sugar) and lactic acidosis.
• Hypoglycemia: Be aware of the symptoms of low blood sugar (e.g., sweating, shaking, rapid heartbeat, confusion) and carry a source of quick-acting sugar, like glucose tablets or juice.
• Pancreatitis: Patients should be monitored for signs and symptoms of pancreatitis, and the medication should be discontinued if suspected.
• Driving: Since this medication can cause dizziness or drowsiness due to changes in blood sugar, caution is advised when driving or operating machinery.

What happens if a dose of GEMER SITA IR 50/1000/2 is missed?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for a missed one.

How should GEMER SITA IR 50/1000/2 be stored?

Store GEMER SITA IR 50/1000/2 at room temperature (20-25°C), or below 30°C. Keep it in a cool, dry place, protected from moisture and light, and out of the sight and reach of children.